News Feed

News Feed

Temple University Renames College of Liberal Arts Main Campus Building in Honor of Citius Pharmaceuticals Executive Chairman Leonard Mazur

October 4, 2021 The Wall Street Analyzer Comments Off on Temple University Renames College of Liberal Arts Main Campus Building in Honor of Citius Pharmaceuticals Executive Chairman Leonard Mazur

Honor recognizes Leonard and Helena Mazur’s philanthropic contributions and continued commitment to Temple University student and alumni professional development […]

No Picture
News Feed

RYAH Group Ships RYAH Smart Dry Herb Inhalers for Use in Pilot Program with Four 20 Pharma in Germany

September 29, 2021 The Wall Street Analyzer Comments Off on RYAH Group Ships RYAH Smart Dry Herb Inhalers for Use in Pilot Program with Four 20 Pharma in Germany

TORONTO, ON / ACCESSWIRE / September 28, 2021 / RYAH Group, Inc. (CSE:RYAH) (“RYAH” or the “Company“) is pleased to announce that it has completed an initial shipment of its proprietary RYAH Smart Dry Herb Inhalers […]

News Feed

African Gold Group Announces 66% Increase in Mineral Reserve to 1.25m Oz at the Kobada Gold Project

September 28, 2021 The Wall Street Analyzer Comments Off on African Gold Group Announces 66% Increase in Mineral Reserve to 1.25m Oz at the Kobada Gold Project

TORONTO, Sept. 27, 2021 (GLOBE NEWSWIRE) — African Gold Group, Inc. (TSX-V: AGG, OTCQX: AGGFF, FRA: 3A61) (“AGG” or the “Company”) is pleased to announce an updated Mineral Reserve Estimate for its Kobada Gold Project […]

News Feed

Golden Independence Intersects 1.71 g/t Gold and 6.0 g/t Silver over 70 Feet at Independence Project

September 21, 2021 The Wall Street Analyzer Comments Off on Golden Independence Intersects 1.71 g/t Gold and 6.0 g/t Silver over 70 Feet at Independence Project

Vancouver, British Columbia – September 21, 2021 – Golden Independence Mining Corp. (CSE: IGLD, OTCQB:GIDMF, FRA:6NN) (the “Company”) is pleased to announce the remaining drill results from its recently completed Phase II drill program at the […]

News Feed

Citius Pharmaceuticals Acquires Dr. Reddy’s Laboratories’ License for Late-Phase 3 Oncology Immunotherapy (E7777) for the Treatment of Cutaneous T-Cell Lymphoma and other Cancer Indications

September 7, 2021 The Wall Street Analyzer Comments Off on Citius Pharmaceuticals Acquires Dr. Reddy’s Laboratories’ License for Late-Phase 3 Oncology Immunotherapy (E7777) for the Treatment of Cutaneous T-Cell Lymphoma and other Cancer Indications

Citius expands late-stage pipeline with the acquisition of Dr. Reddy’s exclusive license rights to E7777, an improved formulation of previously FDA-approved ONTAK®; the exclusive license is with Eisai Co. Ltd.Patient enrollment has been completed in […]